LAMIVUDINE

LAMIVUDINE was reported 25273 times

LAMIVUDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PINEALOBLASTOMA 75 0.8065
1 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 101 0.7829
2 CSF HIV VIRUS IDENTIFIED 18 0.7826
3 CONGENITAL NEOPLASM 21 0.7778
4 GENOTYPE DRUG RESISTANCE TEST 34 0.6939
5 CSF HIV ESCAPE SYNDROME 83 0.6014
6 HIV VIRAEMIA 115 0.5476
7 ULTRASOUND ANTENATAL SCREEN 52 0.5417
8 IMMUNE RECONSTITUTION SYNDROME 626 0.4849
9 VIRAL MUTATION IDENTIFIED 1671 0.4532
10 AIDS ENCEPHALOPATHY 25 0.4310
11 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 119 0.4281
12 GENETIC POLYMORPHISM 24 0.4211
13 HIV ASSOCIATED NEPHROPATHY 20 0.3922
14 TOTAL LUNG CAPACITY INCREASED 103 0.3787
15 VIROLOGIC FAILURE 1960 0.3641
16 AIDS RELATED COMPLICATION 22 0.3385
17 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 33 0.2973
18 MITOCHONDRIAL TOXICITY 235 0.2862
19 LIPODYSTROPHY ACQUIRED 551 0.2593
20 BIRTH MARK 53 0.2548
21 HEPATITIS B VIRUS 20 0.2500
22 ECTOPIC KIDNEY 23 0.2421
23 RETINOBLASTOMA 26 0.2385
24 CONGENITAL TERATOMA 20 0.2326
25 BLOOD HIV RNA INCREASED 419 0.2309
26 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 74 0.2209
27 HEPATITIS B DNA INCREASED 145 0.2151
28 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 103 0.1969
29 PATHOGEN RESISTANCE 1774 0.1944
30 KAPOSI'S SARCOMA 94 0.1873
31 VERTICAL INFECTION TRANSMISSION 21 0.1858
32 ERGOT POISONING 21 0.1680
33 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 766 0.1536
34 CONGENITAL UMBILICAL HERNIA 56 0.1501
35 FANCONI SYNDROME ACQUIRED 261 0.1485
36 CD4 LYMPHOCYTES INCREASED 34 0.1459
37 MITOCHONDRIAL CYTOPATHY 63 0.1432
38 DANDY-WALKER SYNDROME 34 0.1313
39 HEPATITIS B REACTIVATION 402 0.1265
40 LIPOATROPHY 115 0.1208
41 MITOCHONDRIAL MYOPATHY 24 0.1101
42 ACQUIRED GENE MUTATION 142 0.1083
43 RENAL TUBULAR DYSFUNCTION 60 0.1062
44 BONE DEMINERALISATION 112 0.1058
45 TRISOMY 18 39 0.1024
46 GENOTYPE DRUG RESISTANCE TEST POSITIVE 104 0.1012
47 DEXTROCARDIA 19 0.1011
48 FANCONI SYNDROME 143 0.1011
49 OSTEOMALACIA 153 0.0990
50 PNEUMOCYSTIS CARINII PNEUMONIA 20 0.0985
51 MENINGOMYELOCELE 59 0.0983
52 HIV INFECTION 296 0.0981
53 MACROCEPHALY 38 0.0979
54 HEPATITIS B 587 0.0973
55 FACIAL WASTING 26 0.0967
56 HEPATITIS B SURFACE ANTIGEN POSITIVE 26 0.0949
57 HYPOPHOSPHATAEMIC OSTEOMALACIA 25 0.0947
58 FOETAL EXPOSURE DURING DELIVERY 63 0.0929
59 ACQUIRED IMMUNODEFICIENCY SYNDROME 47 0.0906
60 CD4 LYMPHOCYTES DECREASED 177 0.0826
61 CHRONIC DISEASE 21 0.0824
62 HYDROPS FOETALIS 50 0.0816
63 NEUTROPENIA NEONATAL 18 0.0804
64 PSYCHIATRIC DECOMPENSATION 156 0.0798
65 DRUG RESISTANCE 1960 0.0762
66 HYPOURICAEMIA 22 0.0759
67 MENINGITIS CRYPTOCOCCAL 131 0.0749
68 POLYDACTYLY 85 0.0733
69 NODULAR REGENERATIVE HYPERPLASIA 47 0.0732
70 VIRAEMIA 96 0.0693
71 ANAEMIA NEONATAL 33 0.0685
72 MULTIPLE-DRUG RESISTANCE 208 0.0670
73 CUSHING'S SYNDROME 46 0.0662
74 LIPOHYPERTROPHY 40 0.0643
75 PORTAL HYPERTENSIVE GASTROPATHY 36 0.0638
76 MENINGITIS TUBERCULOUS 35 0.0626
77 GASTROSCHISIS 29 0.0609
78 CHRONIC HEPATITIS B 19 0.0599
79 VIRAL LOAD INCREASED 232 0.0597
80 NEURAL TUBE DEFECT 43 0.0591
81 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 27 0.0578
82 TRISOMY 21 72 0.0571
83 BONE METABOLISM DISORDER 17 0.0565
84 GENE MUTATION 110 0.0555
85 ATRIOVENTRICULAR SEPTAL DEFECT 26 0.0553
86 PORTAL HYPERTENSION 169 0.0547
87 CENTRAL NERVOUS SYSTEM INFLAMMATION 18 0.0542
88 CEREBRAL TOXOPLASMOSIS 50 0.0535
89 CONGENITAL HYDROCEPHALUS 27 0.0533
90 CYTOMEGALOVIRUS CHORIORETINITIS 103 0.0528
91 HYPERLACTACIDAEMIA 141 0.0525
92 GLYCOSURIA 69 0.0510
93 BRAIN STEM STROKE 25 0.0507
94 RETINAL TOXICITY 52 0.0505
95 PSYCHOMOTOR SKILLS IMPAIRED 132 0.0503
96 BASEDOW'S DISEASE 23 0.0489
97 OPHTHALMOPLEGIA 77 0.0488
98 RENAL TUBULAR DISORDER 135 0.0479
99 STILLBIRTH 225 0.0465
100 VISCERAL LEISHMANIASIS 33 0.0457
101 CRYPTOCOCCOSIS 74 0.0454
102 CLEFT LIP AND PALATE 50 0.0447
103 LYMPH NODE TUBERCULOSIS 33 0.0444
104 DEATH NEONATAL 61 0.0438
105 BLOOD LACTIC ACID INCREASED 220 0.0417
106 TEMPERATURE REGULATION DISORDER 91 0.0408
107 HYPOMANIA 148 0.0402
108 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 44 0.0400
109 BLOOD BILIRUBIN UNCONJUGATED INCREASED 29 0.0399
110 SYPHILIS 29 0.0399
111 JAUNDICE CHOLESTATIC 141 0.0399
112 ARNOLD-CHIARI MALFORMATION 38 0.0398
113 HEPATITIS A 33 0.0389
114 EAR MALFORMATION 18 0.0389
115 DEPRESSIVE SYMPTOM 136 0.0385
116 HEPATIC FIBROSIS 130 0.0378
117 HIV TEST POSITIVE 25 0.0378
118 MYCOBACTERIUM AVIUM COMPLEX INFECTION 100 0.0372
119 DYSLIPIDAEMIA 189 0.0372
120 ANAEMIA MACROCYTIC 79 0.0370
121 DEPRESSION SUICIDAL 126 0.0364
122 VARICES OESOPHAGEAL 106 0.0350
123 VANISHING BILE DUCT SYNDROME 39 0.0350
124 HEPATOSPLENOMEGALY 89 0.0346
125 PLEOCYTOSIS 20 0.0344
126 UMBILICAL CORD ABNORMALITY 18 0.0342
127 HYPERTRIGLYCERIDAEMIA 199 0.0340
128 PNEUMOCYSTIS JIROVECI PNEUMONIA 75 0.0336
129 FOETAL DEATH 174 0.0335
130 LIPIDS ABNORMAL 24 0.0331
131 TEARFULNESS 138 0.0321
132 EXPOSURE DURING BREAST FEEDING 105 0.0317
133 PULMONARY TUBERCULOSIS 134 0.0313
134 CONGENITAL HYDRONEPHROSIS 22 0.0308
135 FAT TISSUE INCREASED 44 0.0303
136 MYCOBACTERIAL INFECTION 52 0.0302
137 CALCULUS URINARY 46 0.0299
138 MALARIA 21 0.0298
139 RENAL TUBULAR ACIDOSIS 65 0.0298
140 TOXOPLASMOSIS 32 0.0296
141 NEURODEVELOPMENTAL DISORDER 20 0.0296
142 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 32 0.0296
143 OESOPHAGEAL VARICES HAEMORRHAGE 64 0.0295
144 HISTOPLASMOSIS 52 0.0293
145 INTRA-UTERINE DEATH 47 0.0293
146 PYELOCALIECTASIS 28 0.0292
147 NEONATAL DISORDER 46 0.0290
148 CSF PROTEIN INCREASED 24 0.0290
149 CENTRAL OBESITY 21 0.0284
150 NECROTISING RETINITIS 18 0.0281
151 SKULL MALFORMATION 18 0.0280
152 ANHEDONIA 712 0.0271
153 HYDROCELE 28 0.0263
154 VOLVULUS 61 0.0257
155 NEPHRITIS INTERSTITIAL 32 0.0253
156 FOETAL EXPOSURE DURING PREGNANCY 2040 0.0251
157 BONE MARROW TOXICITY 29 0.0245
158 ASEPTIC NECROSIS BONE 19 0.0243
159 LYMPHADENITIS 58 0.0239
160 MICROALBUMINURIA 18 0.0238
161 RHINITIS ALLERGIC 105 0.0236
162 BLOOD AMYLASE INCREASED 40 0.0234
163 PLACENTAL DISORDER 22 0.0233
164 HYPOPHOSPHATAEMIA 171 0.0231
165 HYPOSPADIAS 48 0.0231
166 SPINA BIFIDA 48 0.0230
167 FOETAL GROWTH RETARDATION 18 0.0230
168 NON-HODGKIN'S LYMPHOMA 30 0.0229
169 SARCOIDOSIS 108 0.0227
170 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 24 0.0226
171 PREMATURE RUPTURE OF MEMBRANES 54 0.0224
172 CRYPTORCHISM 25 0.0223
173 LYMPHOCYTIC INFILTRATION 22 0.0218
174 ABORTION INDUCED 205 0.0218
175 LIVE BIRTH 181 0.0216
176 NEPHROPATHY TOXIC 241 0.0214
177 DISSEMINATED TUBERCULOSIS 55 0.0214
178 NASAL POLYPS 105 0.0213
179 CAESAREAN SECTION 248 0.0213
180 EYELID PTOSIS 210 0.0206
181 OPPORTUNISTIC INFECTION 38 0.0205
182 DEVELOPMENTAL HIP DYSPLASIA 17 0.0204
183 OROPHARYNGEAL CANDIDIASIS 18 0.0199
184 OESOPHAGEAL CANDIDIASIS 79 0.0198
185 OSTEOPENIA 296 0.0195
186 ECONOMIC PROBLEM 293 0.0193
187 ATYPICAL MYCOBACTERIAL INFECTION 27 0.0191
188 CACHEXIA 98 0.0190
189 VENTRICULAR SEPTAL DEFECT 109 0.0190
190 MACROCYTOSIS 22 0.0190
191 NECROTISING COLITIS 24 0.0189
192 SCHIZOPHRENIA 228 0.0187
193 SMALL FOR DATES BABY 93 0.0187
194 STRONGYLOIDIASIS 30 0.0186
195 POSTPARTUM HAEMORRHAGE 25 0.0185
196 DRUG EXPOSURE DURING PREGNANCY 631 0.0185
197 HEPATIC NEOPLASM MALIGNANT 39 0.0184
198 CARDIAC MURMUR 158 0.0182
199 FOETAL GROWTH RESTRICTION 111 0.0182
200 HYPERPHOSPHATAEMIA 39 0.0181
201 MATERNAL DRUGS AFFECTING FOETUS 137 0.0179
202 LIVER TRANSPLANT REJECTION 32 0.0178
203 HEPATORENAL SYNDROME 30 0.0178
204 FOETAL DISTRESS SYNDROME 37 0.0174
205 PORTAL VEIN THROMBOSIS 56 0.0173
206 GENITAL HERPES 26 0.0170
207 BLOOD PHOSPHORUS DECREASED 62 0.0169
208 HEPATOTOXICITY 377 0.0169
209 NEUROMYOPATHY 18 0.0169
210 HEPATOMEGALY 166 0.0169
211 BRONCHIECTASIS 112 0.0166
212 BLOOD BICARBONATE DECREASED 31 0.0164
213 CYTOLYTIC HEPATITIS 54 0.0163
214 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 134 0.0162
215 LOW BIRTH WEIGHT BABY 128 0.0161
216 HEPATITIS FULMINANT 47 0.0158
217 HEPATITIS E 25 0.0158
218 PREMATURE BABY 475 0.0158
219 OSTEOPOROTIC FRACTURE 30 0.0157
220 HYPERBILIRUBINAEMIA 162 0.0156
221 CEREBRAL VENTRICLE DILATATION 18 0.0156
222 OPTIC ATROPHY 25 0.0153
223 PSYCHOMOTOR RETARDATION 43 0.0153
224 END STAGE RENAL DISEASE 279 0.0153
225 HISTOPLASMOSIS DISSEMINATED 24 0.0151
226 PREGNANCY ON CONTRACEPTIVE 22 0.0151
227 HEPATIC ENCEPHALOPATHY 140 0.0150
228 GLUCOSE URINE PRESENT 19 0.0149
229 TALIPES 46 0.0148
230 ENTHESOPATHY 23 0.0147
231 CEREBELLAR SYNDROME 32 0.0146
232 ATRIAL SEPTAL DEFECT 121 0.0144
233 RENAL ATROPHY 18 0.0144
234 HYPERLIPIDAEMIA 170 0.0142
235 EXPOSURE DURING PREGNANCY 884 0.0142
236 HEPATIC NECROSIS 53 0.0141
237 MICROCEPHALY 18 0.0140
238 HEPATITIS C 169 0.0140
239 ENCEPHALITIS VIRAL 17 0.0140
240 HYPERPARATHYROIDISM SECONDARY 35 0.0140
241 SECONDARY ADRENOCORTICAL INSUFFICIENCY 21 0.0139
242 BLOOD BILIRUBIN INCREASED 375 0.0139
243 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 20 0.0138
244 LIVER TRANSPLANT 50 0.0137
245 STRABISMUS 40 0.0136
246 SPEECH DISORDER DEVELOPMENTAL 39 0.0136
247 HEPATITIS CHOLESTATIC 80 0.0133
248 HYPERPARATHYROIDISM 27 0.0131
249 HEPATIC FAILURE 390 0.0129
250 HYDROCEPHALUS 70 0.0128
251 PROTEINURIA 244 0.0128
252 PREMATURE LABOUR 72 0.0127
253 PRE-ECLAMPSIA 60 0.0126
254 TREATMENT FAILURE 1028 0.0124
255 OSTEOPOROSIS 504 0.0122
256 NEONATAL RESPIRATORY DISTRESS SYNDROME 43 0.0121
257 GRANULOMA 42 0.0121
258 TREATMENT NONCOMPLIANCE 663 0.0121
259 HAEMANGIOMA 28 0.0121
260 QUADRIPARESIS 20 0.0120
261 SPLENOMEGALY 140 0.0119
262 RENAL COLIC 27 0.0119
263 GENITAL RASH 17 0.0119
264 JC VIRUS INFECTION 19 0.0119
265 PREMATURE DELIVERY 189 0.0119
266 DRUG INTERACTION 1871 0.0118
267 PARAPARESIS 21 0.0118
268 PARADOXICAL DRUG REACTION 43 0.0117
269 CHOLESTATIC LIVER INJURY 26 0.0117
270 ABORTION SPONTANEOUS 461 0.0115
271 FOOD ALLERGY 88 0.0114
272 PREGNANCY 227 0.0113
273 AREFLEXIA 30 0.0112
274 HEPATIC CIRRHOSIS 210 0.0112
275 HEPATITIS TOXIC 29 0.0111
276 PSYCHOTIC DISORDER 328 0.0111
277 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 36 0.0111
278 ECTOPIC PREGNANCY 34 0.0110
279 LACTIC ACIDOSIS 357 0.0110
280 JAUNDICE 292 0.0108
281 VITRITIS 20 0.0108
282 BONE DENSITY DECREASED 336 0.0107
283 ORAL CANDIDIASIS 141 0.0107
284 HYPERURICAEMIA 44 0.0107
285 BILIRUBIN CONJUGATED INCREASED 25 0.0107
286 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 35 0.0106
287 TETANY 19 0.0104
288 ACUTE LYMPHOCYTIC LEUKAEMIA 29 0.0102
289 LUNG NEOPLASM 43 0.0101
290 ALANINE AMINOTRANSFERASE INCREASED 618 0.0101
291 MYELOPATHY 19 0.0100
292 NORMAL NEWBORN 54 0.0099
293 LYMPHADENOPATHY MEDIASTINAL 19 0.0099
294 APLASIA PURE RED CELL 34 0.0099
295 HEPATOCELLULAR CARCINOMA 75 0.0099
296 HEPATITIS 249 0.0097
297 DRUG-INDUCED LIVER INJURY 304 0.0097
298 NEPHROPATHY 90 0.0096
299 EXPOSURE VIA BREAST MILK 38 0.0095
300 ENCEPHALITIS 66 0.0095
301 RENAL IMPAIRMENT 790 0.0094
302 CUSHINGOID 30 0.0093
303 OLIGOHYDRAMNIOS 31 0.0093
304 RENAL TUBULAR NECROSIS 91 0.0093
305 GAMMA-GLUTAMYLTRANSFERASE INCREASED 205 0.0092
306 RENAL TRANSPLANT 33 0.0091
307 LYMPHADENOPATHY 323 0.0091
308 ASPARTATE AMINOTRANSFERASE INCREASED 484 0.0091
309 DERMATITIS EXFOLIATIVE 45 0.0090
310 COMPLICATIONS OF TRANSPLANTED KIDNEY 20 0.0088
311 CHOLELITHIASIS 289 0.0088
312 BLOOD ALKALINE PHOSPHATASE INCREASED 217 0.0087
313 PRESCRIBED OVERDOSE 169 0.0087
314 STEVENS-JOHNSON SYNDROME 194 0.0087
315 CHRONIC KIDNEY DISEASE 659 0.0087
316 BLOOD URIC ACID INCREASED 50 0.0087
317 INSULIN RESISTANCE 18 0.0086
318 ASCITES 254 0.0086
319 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 413 0.0086
320 OCULAR ICTERUS 37 0.0085
321 CREATININE RENAL CLEARANCE DECREASED 34 0.0085
322 COELIAC DISEASE 83 0.0085
323 FIBROSIS 26 0.0084
324 INTRACRANIAL PRESSURE INCREASED 47 0.0084
325 PROTEIN URINE PRESENT 42 0.0084
326 HISTIOCYTOSIS HAEMATOPHAGIC 25 0.0084
327 TRANSPLANT REJECTION 67 0.0084
328 LIPASE INCREASED 64 0.0083
329 DRUG TOXICITY 113 0.0083
330 CONGENITAL ANOMALY 64 0.0083
331 ACUTE HEPATIC FAILURE 110 0.0080
332 NEUROLOGICAL SYMPTOM 46 0.0080
333 BK VIRUS INFECTION 27 0.0080
334 PARANOIA 138 0.0080
335 PNEUMOCYSTIS JIROVECII PNEUMONIA 80 0.0080
336 IMMUNODEFICIENCY 118 0.0079
337 LICHENOID KERATOSIS 18 0.0079
338 PATHOLOGICAL FRACTURE 40 0.0079
339 HYPERCHOLESTEROLAEMIA 76 0.0079
340 MULTIPLE FRACTURES 128 0.0078
341 MYOPATHY 67 0.0077
342 BLOOD TRIGLYCERIDES INCREASED 137 0.0077
343 TRANSAMINASES INCREASED 171 0.0077
344 HYPERTONIA 44 0.0077
345 DYSMORPHISM 18 0.0076
346 BLOOD CREATININE INCREASED 498 0.0076
347 FEMORAL NECK FRACTURE 39 0.0076
348 PATENT DUCTUS ARTERIOSUS 30 0.0075
349 LEUKOENCEPHALOPATHY 28 0.0075
350 ANOREXIA 96 0.0074
351 BLOOD ALBUMIN DECREASED 59 0.0074
352 CYTOMEGALOVIRUS COLITIS 17 0.0074
353 HEPATIC FUNCTION ABNORMAL 273 0.0073
354 LUNG ADENOCARCINOMA 22 0.0073
355 HERPES SIMPLEX 47 0.0072
356 CANDIDIASIS 29 0.0072
357 DECREASED ACTIVITY 78 0.0072
358 BURSITIS 87 0.0072
359 DIPLOPIA 186 0.0072
360 ATTENTION DEFICIT HYPERACTIVITY DISORDER 30 0.0071
361 QUALITY OF LIFE DECREASED 95 0.0071
362 UMBILICAL HERNIA 33 0.0071
363 METABOLIC ACIDOSIS 224 0.0070
364 MULTI-ORGAN FAILURE 121 0.0070
365 GLOMERULONEPHRITIS 17 0.0069
366 OSTEONECROSIS 228 0.0069
367 NEPHROGENIC ANAEMIA 32 0.0069
368 METABOLIC DISORDER 40 0.0069
369 CHOLESTASIS 132 0.0069
370 MATERNAL EXPOSURE DURING PREGNANCY 605 0.0068
371 RENAL FAILURE ACUTE 287 0.0068
372 EMOTIONAL DISTRESS 808 0.0067
373 BLOOD CREATINE PHOSPHOKINASE INCREASED 192 0.0067
374 ENTEROCOCCAL INFECTION 32 0.0066
375 CYTOMEGALOVIRUS INFECTION 110 0.0066
376 BLOOD PHOSPHORUS INCREASED 18 0.0066
377 FAILURE TO THRIVE 34 0.0065
378 STAPHYLOCOCCAL SEPSIS 32 0.0065
379 CONGESTIVE CARDIOMYOPATHY 27 0.0065
380 BLOOD LACTATE DEHYDROGENASE INCREASED 101 0.0064
381 DRUG LEVEL BELOW THERAPEUTIC 35 0.0063
382 HEPATIC STEATOSIS 118 0.0063
383 RENAL FAILURE 841 0.0063
384 NECROSIS 35 0.0063
385 ILEUS PARALYTIC 28 0.0063
386 CEREBRAL ATROPHY 25 0.0063
387 HYPOTONIA 62 0.0062
388 DISSEMINATED INTRAVASCULAR COAGULATION 87 0.0062
389 VITAMIN D DEFICIENCY 60 0.0061
390 HYDRONEPHROSIS 46 0.0061
391 BACTERIAL SEPSIS 20 0.0061
392 NEPHROTIC SYNDROME 42 0.0061
393 TOXIC EPIDERMAL NECROLYSIS 93 0.0061
394 AUTOIMMUNE THYROIDITIS 23 0.0061
395 HERPES VIRUS INFECTION 35 0.0061
396 HYPOALBUMINAEMIA 47 0.0060
397 HEPATIC CYTOLYSIS 77 0.0060
398 TACHYPNOEA 82 0.0060
399 HYPERREFLEXIA 21 0.0060
400 ATAXIA 71 0.0060
401 HEART DISEASE CONGENITAL 21 0.0059
402 HEPATIC ENZYME INCREASED 404 0.0059
403 ANAEMIA 1126 0.0059
404 DEPRESSION 1343 0.0059
405 PERIPHERAL ISCHAEMIA 24 0.0059
406 DYSAESTHESIA 18 0.0059
407 GASTROENTERITIS 85 0.0058
408 LOW DENSITY LIPOPROTEIN INCREASED 45 0.0058
409 PAPILLOEDEMA 26 0.0058
410 GLUCOSE TOLERANCE IMPAIRED 34 0.0057
411 CREPITATIONS 17 0.0057
412 HEPATITIS ACUTE 37 0.0057
413 MACULOPATHY 20 0.0056
414 TORSADE DE POINTES 44 0.0056
415 EPSTEIN-BARR VIRUS INFECTION 35 0.0056
416 BRONCHOPNEUMONIA 19 0.0055
417 CHEST X-RAY ABNORMAL 17 0.0055
418 GLOMERULAR FILTRATION RATE DECREASED 68 0.0055
419 RASH MACULO-PAPULAR 123 0.0055
420 PANCYTOPENIA 308 0.0055
421 POLYNEUROPATHY 65 0.0054
422 DRUG LEVEL INCREASED 89 0.0054
423 DEVELOPMENTAL DELAY 48 0.0053
424 NYSTAGMUS 28 0.0053
425 ADRENAL INSUFFICIENCY 64 0.0053
426 GESTATIONAL DIABETES 25 0.0052
427 LEFT VENTRICULAR DYSFUNCTION 35 0.0052
428 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 39 0.0052
429 LYMPHOMA 80 0.0052
430 HEMIPLEGIA 43 0.0052
431 PROTHROMBIN TIME PROLONGED 30 0.0050
432 RALES 29 0.0050
433 MALABSORPTION 26 0.0050
434 CORONARY ARTERY STENOSIS 25 0.0050
435 MENINGITIS 33 0.0049
436 DIFFICULTY IN WALKING 17 0.0049
437 BONE MARROW FAILURE 100 0.0049
438 BRAIN OEDEMA 62 0.0049
439 GOITRE 20 0.0049
440 AMYLASE INCREASED 18 0.0049
441 BONE LOSS 73 0.0049
442 ACIDOSIS 37 0.0048
443 CHOLANGITIS 30 0.0048
444 RENAL FAILURE CHRONIC 37 0.0048
445 POLYDIPSIA 19 0.0048
446 ATRIOVENTRICULAR BLOCK COMPLETE 32 0.0048
447 GUILLAIN-BARRE SYNDROME 23 0.0048
448 MUSCLE HAEMORRHAGE 19 0.0047
449 BRONCHOPULMONARY ASPERGILLOSIS 36 0.0046
450 TUBULOINTERSTITIAL NEPHRITIS 87 0.0046
451 LUNG INFILTRATION 41 0.0046
452 SPINAL COMPRESSION FRACTURE 38 0.0046
453 FOOT FRACTURE 86 0.0045
454 COAGULOPATHY 75 0.0045
455 MALNUTRITION 50 0.0045
456 BENIGN PROSTATIC HYPERPLASIA 23 0.0044
457 VISUAL FIELD DEFECT 32 0.0044
458 CENTRAL NERVOUS SYSTEM LESION 60 0.0044
459 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 74 0.0043
460 TIBIA FRACTURE 20 0.0043
461 ENCEPHALOPATHY 104 0.0042
462 APLASTIC ANAEMIA 22 0.0042
463 NEUTROPENIC SEPSIS 30 0.0042
464 NERVOUS SYSTEM DISORDER 131 0.0042
465 HEMIPARESIS 71 0.0042
466 RENAL INJURY 124 0.0042
467 NEUROTOXICITY 73 0.0042
468 PYELONEPHRITIS 36 0.0042
469 KLEBSIELLA INFECTION 21 0.0041
470 THROMBOCYTOPENIA 464 0.0041
471 LEUKOPENIA 207 0.0041
472 PANCREATITIS ACUTE 93 0.0041
473 SKIN LESION 113 0.0041
474 TOOTH LOSS 85 0.0041
475 NEPHROLITHIASIS 188 0.0041
476 LIVER DISORDER 180 0.0041
477 RIB FRACTURE 83 0.0040
478 LIVER INJURY 99 0.0040
479 HAEMOLYSIS 31 0.0040
480 HYPERTHYROIDISM 58 0.0040
481 INTESTINAL ISCHAEMIA 22 0.0040
482 KIDNEY TRANSPLANT REJECTION 19 0.0040
483 PURPURA 35 0.0040
484 PANCREATITIS 207 0.0039
485 CHOLECYSTITIS ACUTE 22 0.0039
486 AUTOIMMUNE HEPATITIS 27 0.0039
487 GRANULOCYTOPENIA 22 0.0039
488 IMMUNOSUPPRESSION 34 0.0039
489 ODYNOPHAGIA 23 0.0038
490 HYPERKALAEMIA 135 0.0038
491 CYTOMEGALOVIRUS INFECTION REACTIVATION 17 0.0038
492 BLOOD CREATINE INCREASED 17 0.0038
493 CYTOMEGALOVIRUS VIRAEMIA 17 0.0038
494 PNEUMONIA BACTERIAL 35 0.0038
495 SUBCUTANEOUS ABSCESS 18 0.0038
496 RHINITIS 30 0.0037
497 LIVER FUNCTION TEST ABNORMAL 108 0.0037
498 PYREXIA 1279 0.0037
499 VASCULITIS 43 0.0037
500 MYOSITIS 33 0.0037
501 SKELETAL INJURY 38 0.0037
502 APPETITE DISORDER 24 0.0036
503 HAEMATOTOXICITY 34 0.0036
504 GRAND MAL CONVULSION 33 0.0036
505 DEFAECATION URGENCY 25 0.0036
506 PAPULE 25 0.0035
507 EYELID OEDEMA 41 0.0035
508 BOWEL MOVEMENT IRREGULARITY 27 0.0035
509 STRESS FRACTURE 19 0.0035
510 MULTIPLE ORGAN DYSFUNCTION SYNDROME 99 0.0035
511 CLOSTRIDIUM DIFFICILE COLITIS 37 0.0035
512 LYMPHOEDEMA 24 0.0035
513 SEPTIC SHOCK 151 0.0035
514 SKIN NECROSIS 18 0.0035
515 ANXIETY 987 0.0035
516 HAEMOLYTIC ANAEMIA 31 0.0035
517 RESPIRATORY DISTRESS 95 0.0034
518 DRUG LEVEL DECREASED 35 0.0034
519 ACUTE MYOCARDIAL INFARCTION 101 0.0034
520 ABDOMINAL TENDERNESS 17 0.0034
521 POLYURIA 28 0.0034
522 ANURIA 29 0.0034
523 DECREASED IMMUNE RESPONSIVENESS 33 0.0034
524 ACUTE KIDNEY INJURY 512 0.0033
525 NEUTROPENIA 454 0.0033
526 TYPE 1 DIABETES MELLITUS 20 0.0033
527 DIABETES MELLITUS 251 0.0033
528 SOCIAL AVOIDANT BEHAVIOUR 19 0.0033
529 DIALYSIS 46 0.0032
530 MUSCLE ATROPHY 41 0.0032
531 HAEMODIALYSIS 27 0.0032
532 NEUROPATHY PERIPHERAL 305 0.0032
533 SKIN PLAQUE 27 0.0032
534 ABSCESS 51 0.0032
535 SKIN TOXICITY 18 0.0032
536 HYPOKALAEMIA 147 0.0032
537 RENAL DISORDER 148 0.0032
538 DISEASE RECURRENCE 151 0.0032
539 UVEITIS 43 0.0032
540 RASH ERYTHEMATOUS 150 0.0031
541 PULMONARY HYPERTENSION 65 0.0031
542 DERMATITIS ALLERGIC 39 0.0031
543 TOXIC SKIN ERUPTION 31 0.0031
544 GENERALISED OEDEMA 38 0.0031
545 RESPIRATORY RATE INCREASED 27 0.0030
546 SKIN HYPERPIGMENTATION 26 0.0030
547 RHABDOMYOLYSIS 126 0.0030
548 PLATELET COUNT INCREASED 39 0.0030
549 ARTERIOSCLEROSIS 28 0.0030
550 CONTRAINDICATED PRODUCT ADMINISTERED 90 0.0030
551 EOSINOPHILIA 52 0.0030
552 HAND FRACTURE 21 0.0030
553 HEPATOCELLULAR INJURY 42 0.0030
554 AGRANULOCYTOSIS 55 0.0030
555 EXERCISE TOLERANCE DECREASED 17 0.0030
556 NO THERAPEUTIC RESPONSE 36 0.0029
557 ACUTE RESPIRATORY DISTRESS SYNDROME 52 0.0029
558 HYPERGLYCAEMIA 107 0.0029
559 CONJUNCTIVITIS 54 0.0029
560 DRUG ERUPTION 51 0.0029
561 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 25 0.0028
562 MITRAL VALVE INCOMPETENCE 32 0.0028
563 BLOOD UREA INCREASED 47 0.0028
564 DIARRHOEA HAEMORRHAGIC 26 0.0028
565 CARDIOMYOPATHY 41 0.0028
566 LUNG NEOPLASM MALIGNANT 114 0.0028
567 ULCER 44 0.0028
568 DERMATITIS BULLOUS 20 0.0028
569 BLOOD SODIUM DECREASED 52 0.0028
570 RESPIRATORY FAILURE 201 0.0028
571 WRIST FRACTURE 33 0.0028
572 RASH PUSTULAR 20 0.0027
573 REBOUND EFFECT 31 0.0027
574 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 143 0.0027
575 SEPSIS 305 0.0027
576 IMMUNE SYSTEM DISORDER 36 0.0027
577 ELECTROCARDIOGRAM QT PROLONGED 98 0.0027
578 PSEUDOMONAS INFECTION 23 0.0027
579 ERYTHEMA MULTIFORME 25 0.0027
580 SINUS TACHYCARDIA 38 0.0027
581 PARKINSONISM 26 0.0027
582 GASTRITIS 70 0.0027
583 RENAL CYST 21 0.0026
584 BACTERIAL INFECTION 49 0.0026
585 CHOLECYSTITIS 31 0.0026
586 CARDIOMEGALY 32 0.0026
587 VENTRICULAR EXTRASYSTOLES 27 0.0026
588 MAJOR DEPRESSION 19 0.0026
589 PALLOR 70 0.0026
590 CEREBRAL DISORDER 19 0.0026
591 STATUS EPILEPTICUS 29 0.0026
592 MUCOSAL INFLAMMATION 67 0.0026
593 UPPER RESPIRATORY TRACT INFECTION 118 0.0026
594 HYPOCALCAEMIA 48 0.0025
595 MYOCARDITIS 29 0.0025
596 ELECTROLYTE IMBALANCE 29 0.0025
597 FACE OEDEMA 42 0.0025
598 EYE MOVEMENT DISORDER 17 0.0025
599 CHROMATURIA 56 0.0025
600 LYMPHOPENIA 35 0.0025
601 FEBRILE NEUTROPENIA 163 0.0025
602 GYNAECOMASTIA 76 0.0025
603 ANKLE FRACTURE 38 0.0025
604 GENERAL PHYSICAL HEALTH DETERIORATION 284 0.0025
605 RENAL PAIN 26 0.0025
606 THERAPY NON-RESPONDER 110 0.0024
607 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 23 0.0024
608 HAEMATURIA 82 0.0024
609 CONDITION AGGRAVATED 726 0.0024
610 INTERVERTEBRAL DISC DEGENERATION 22 0.0024
611 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 61 0.0024
612 CANDIDA INFECTION 40 0.0024
613 DELIRIUM 82 0.0024
614 APPENDICITIS 22 0.0024
615 OEDEMA PERIPHERAL 285 0.0023
616 PERICARDIAL EFFUSION 54 0.0023
617 DYSSTASIA 67 0.0023
618 ACUTE CORONARY SYNDROME 19 0.0023
619 FLUID RETENTION 116 0.0023
620 CONVULSION 130 0.0023
621 HYPERCALCAEMIA 28 0.0023
622 HAEMOGLOBIN DECREASED 232 0.0023
623 PHARYNGITIS 28 0.0023
624 ACUTE MYELOID LEUKAEMIA 35 0.0022
625 PLEURAL EFFUSION 136 0.0022
626 SUICIDAL IDEATION 203 0.0022
627 SKIN ULCER 57 0.0022
628 HYPONATRAEMIA 124 0.0022
629 BACTERAEMIA 26 0.0022
630 CORONARY ARTERY DISEASE 66 0.0022
631 DYSARTHRIA 82 0.0022
632 VOMITING 1023 0.0022
633 SUDDEN DEATH 23 0.0022
634 URINE OUTPUT DECREASED 19 0.0022
635 DRUG INTOLERANCE 209 0.0022
636 BONE PAIN 126 0.0021
637 DEAFNESS 56 0.0021
638 BONE DISORDER 39 0.0021
639 SQUAMOUS CELL CARCINOMA 20 0.0021
640 HYPERTENSION 449 0.0021
641 FRACTURE 40 0.0021
642 TENDERNESS 22 0.0021
643 DYSPHAGIA 200 0.0021
644 GASTROOESOPHAGEAL REFLUX DISEASE 169 0.0021
645 PARALYSIS 30 0.0021
646 INCONTINENCE 22 0.0021
647 PNEUMOTHORAX 33 0.0021
648 VISUAL ACUITY REDUCED 69 0.0021
649 HYPOTHERMIA 21 0.0021
650 GASTROINTESTINAL DISORDER 184 0.0021
651 HAEMATEMESIS 52 0.0020
652 RASH GENERALISED 53 0.0020
653 BLOOD CALCIUM DECREASED 23 0.0020
654 SUBDURAL HAEMATOMA 29 0.0020
655 UPPER GASTROINTESTINAL HAEMORRHAGE 34 0.0020
656 IMPAIRED WORK ABILITY 43 0.0020
657 MASS 28 0.0020
658 STAPHYLOCOCCAL INFECTION 66 0.0020
659 BRAIN INJURY 20 0.0020
660 FACIAL PARALYSIS 17 0.0020
661 GENERALISED TONIC-CLONIC SEIZURE 33 0.0020
662 TYPE 2 DIABETES MELLITUS 67 0.0020
663 HYPOXIA 70 0.0020
664 ABDOMINAL PAIN 462 0.0020
665 APHASIA 59 0.0020
666 THROMBOTIC MICROANGIOPATHY 19 0.0019
667 GASTRIC ULCER 37 0.0019
668 DISORIENTATION 77 0.0019
669 WHEEZING 115 0.0019
670 VENTRICULAR TACHYCARDIA 32 0.0019
671 TENDONITIS 30 0.0019
672 ILEUS 24 0.0019
673 LUNG INFECTION 30 0.0019
674 ACUTE RESPIRATORY FAILURE 37 0.0019
675 OESOPHAGITIS 21 0.0019
676 FLANK PAIN 18 0.0019
677 INTENTIONAL PRODUCT USE ISSUE 168 0.0019
678 NODULE 25 0.0019
679 OEDEMA 103 0.0019
680 C-REACTIVE PROTEIN INCREASED 69 0.0019
681 VIRAL INFECTION 63 0.0019
682 INFLAMMATION 97 0.0019
683 SHOCK 43 0.0019
684 ERECTILE DYSFUNCTION 48 0.0019
685 MOTOR DYSFUNCTION 19 0.0019
686 PLATELET COUNT DECREASED 198 0.0019
687 PNEUMONIA 599 0.0018
688 PAIN 1122 0.0018
689 LEUKOCYTOSIS 33 0.0018
690 BLOOD CHOLESTEROL INCREASED 85 0.0018
691 MOBILITY DECREASED 131 0.0018
692 NERVE INJURY 20 0.0018
693 SPINAL FRACTURE 36 0.0018
694 COORDINATION ABNORMAL 25 0.0018
695 RASH PAPULAR 40 0.0018
696 WEIGHT DECREASED 496 0.0018
697 AFFECT LABILITY 17 0.0018
698 HAEMATOCRIT DECREASED 35 0.0018
699 INTERNATIONAL NORMALISED RATIO INCREASED 50 0.0018
700 CORONARY ARTERY OCCLUSION 24 0.0017
701 RESTLESSNESS 64 0.0017
702 ANGINA PECTORIS 50 0.0017
703 MENTAL STATUS CHANGES 48 0.0017
704 WEIGHT FLUCTUATION 18 0.0017
705 APATHY 25 0.0017
706 HYPERTENSIVE CRISIS 19 0.0017
707 BLINDNESS 69 0.0017
708 HYPOTHYROIDISM 54 0.0017
709 ASTHENIA 633 0.0017
710 MELAENA 37 0.0017
711 DYSPNOEA EXERTIONAL 63 0.0017
712 SEROTONIN SYNDROME 32 0.0017
713 BLOOD POTASSIUM INCREASED 27 0.0017
714 MOUTH ULCERATION 35 0.0017
715 INFUSION RELATED REACTION 110 0.0017
716 AMENORRHOEA 29 0.0017
717 CYANOSIS 26 0.0017
718 CEREBRAL HAEMORRHAGE 59 0.0016
719 DEPRESSED LEVEL OF CONSCIOUSNESS 65 0.0016
720 FOLLICULITIS 17 0.0016
721 TACHYCARDIA 144 0.0016
722 MOVEMENT DISORDER 52 0.0016
723 HERPES ZOSTER 93 0.0016
724 LETHARGY 93 0.0016
725 ABDOMINAL DISTENSION 168 0.0016
726 HYPERHIDROSIS 207 0.0016
727 MUSCULAR WEAKNESS 182 0.0016
728 INTERSTITIAL LUNG DISEASE 77 0.0016
729 NIGHTMARE 55 0.0016
730 MENTAL DISORDER 69 0.0016
731 CIRCULATORY COLLAPSE 27 0.0016
732 BODY TEMPERATURE INCREASED 32 0.0016
733 CEREBRAL INFARCTION 38 0.0016
734 TOXICITY TO VARIOUS AGENTS 262 0.0016
735 PERICARDITIS 26 0.0015
736 NEOPLASM PROGRESSION 53 0.0015
737 ABNORMAL DREAMS 42 0.0015
738 HYPOKINESIA 22 0.0015
739 COMA 72 0.0015
740 LUNG DISORDER 74 0.0015
741 GOUT 27 0.0015
742 PERITONITIS 31 0.0015
743 INFECTION 216 0.0015
744 HYPOPHAGIA 38 0.0015
745 GAIT DISTURBANCE 284 0.0015
746 ALTERED STATE OF CONSCIOUSNESS 32 0.0015
747 PULMONARY MASS 22 0.0015
748 WHITE BLOOD CELL COUNT DECREASED 160 0.0015
749 HAEMOPTYSIS 41 0.0015
750 DYSURIA 54 0.0015
751 MYALGIA 248 0.0015
752 ABASIA 36 0.0015
753 NEURALGIA 35 0.0014
754 RESPIRATORY TRACT INFECTION 37 0.0014
755 RED BLOOD CELL COUNT DECREASED 40 0.0014
756 METASTASES TO CENTRAL NERVOUS SYSTEM 18 0.0014
757 CARDIAC FAILURE 112 0.0014
758 DECREASED APPETITE 324 0.0014
759 PULMONARY ARTERIAL HYPERTENSION 20 0.0014
760 RESPIRATORY DISORDER 41 0.0014
761 NAUSEA 1079 0.0014
762 HYPERSENSITIVITY 250 0.0013
763 CONFUSIONAL STATE 217 0.0013
764 PULMONARY OEDEMA 60 0.0013
765 DEEP VEIN THROMBOSIS 87 0.0013
766 INTENTIONAL PRODUCT MISUSE 117 0.0013
767 DISTURBANCE IN ATTENTION 72 0.0013
768 SLEEP DISORDER 94 0.0013
769 SYNOVITIS 24 0.0013
770 DEHYDRATION 177 0.0013
771 FEMUR FRACTURE 41 0.0013
772 HALLUCINATION, AUDITORY 21 0.0013
773 DIARRHOEA 847 0.0013
774 RASH 570 0.0013
775 LIVER FUNCTION TEST INCREASED 28 0.0013
776 NIGHT SWEATS 42 0.0013
777 NEUTROPHIL COUNT DECREASED 53 0.0013
778 PNEUMONITIS 35 0.0013
779 PNEUMONIA ASPIRATION 32 0.0013
780 PHOTOPHOBIA 24 0.0013
781 EYE HAEMORRHAGE 17 0.0013
782 OSTEOARTHRITIS 54 0.0013
783 POLLAKIURIA 53 0.0013
784 BRADYCARDIA 67 0.0013
785 MUSCULOSKELETAL DISORDER 24 0.0013
786 BACK PAIN 292 0.0013
787 GASTROINTESTINAL HAEMORRHAGE 105 0.0013
788 DISEASE PROGRESSION 148 0.0012
789 COGNITIVE DISORDER 58 0.0012
790 DERMATITIS 26 0.0012
791 HIP ARTHROPLASTY 19 0.0012
792 BLOOD POTASSIUM DECREASED 37 0.0012
793 MUSCULOSKELETAL CHEST PAIN 19 0.0012
794 AGITATION 90 0.0012
795 LABORATORY TEST ABNORMAL 36 0.0012
796 PHOTOSENSITIVITY REACTION 20 0.0012
797 HAEMORRHAGE INTRACRANIAL 18 0.0012
798 INTERVERTEBRAL DISC PROTRUSION 26 0.0012
799 PRODUCT USE IN UNAPPROVED INDICATION 294 0.0012
800 CHILLS 139 0.0012
801 EPILEPSY 36 0.0012
802 HYPOAESTHESIA 176 0.0012
803 DIABETIC KETOACIDOSIS 28 0.0012
804 EYE DISORDER 38 0.0012
805 COUGH 324 0.0012
806 UPPER LIMB FRACTURE 23 0.0012
807 DEPRESSED MOOD 61 0.0012
808 RASH MACULAR 40 0.0011
809 LYMPHOCYTE COUNT DECREASED 20 0.0011
810 FEAR 30 0.0011
811 METRORRHAGIA 19 0.0011
812 MYELOSUPPRESSION 40 0.0011
813 CARDIAC ARREST 91 0.0011
814 ASTHMA 124 0.0011
815 SWELLING FACE 71 0.0011
816 PRODUCTIVE COUGH 52 0.0011
817 IRRITABILITY 65 0.0011
818 SKIN DISORDER 36 0.0011
819 RETCHING 23 0.0011
820 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 76 0.0011
821 PULMONARY EMBOLISM 101 0.0011
822 HYPOTENSION 211 0.0011
823 MYOCARDIAL INFARCTION 183 0.0010
824 PRODUCT USE ISSUE 197 0.0010
825 URINARY INCONTINENCE 31 0.0010
826 LOWER LIMB FRACTURE 20 0.0010
827 ACCIDENTAL OVERDOSE 38 0.0010
828 OVERDOSE 224 0.0010
829 RASH PRURITIC 56 0.0010
830 HYPOGLYCAEMIA 50 0.0010
831 ABDOMINAL PAIN LOWER 26 0.0010
832 AGGRESSION 51 0.0010
833 JOINT SWELLING 123 0.0010
834 PRURITUS GENERALISED 22 0.0010
835 DIABETES MELLITUS INADEQUATE CONTROL 18 0.0010
836 CHEST PAIN 188 0.0010
837 ABNORMAL BEHAVIOUR 40 0.0010
838 THIRST 18 0.0010
839 COLITIS 38 0.0010
840 DISCOMFORT 61 0.0010
841 FATIGUE 776 0.0010
842 HALLUCINATION 75 0.0010
843 HIP FRACTURE 32 0.0010
844 ANGIOEDEMA 44 0.0010
845 ARRHYTHMIA 47 0.0010
846 SPEECH DISORDER 52 0.0010
847 PALPITATIONS 116 0.0010
848 SUICIDE ATTEMPT 60 0.0010
849 FEEDING DISORDER 20 0.0010
850 BLOOD PRESSURE SYSTOLIC INCREASED 19 0.0010
851 CELLULITIS 49 0.0010
852 FAECES DISCOLOURED 21 0.0010
853 RHEUMATOID ARTHRITIS 109 0.0010
854 MUSCULOSKELETAL PAIN 50 0.0010
855 HALLUCINATION, VISUAL 20 0.0009
856 INSOMNIA 252 0.0009
857 LOWER RESPIRATORY TRACT INFECTION 43 0.0009
858 ERYTHEMA 194 0.0009
859 OFF LABEL USE 809 0.0009
860 PSORIASIS 120 0.0009
861 WHITE BLOOD CELL COUNT INCREASED 35 0.0009
862 DYSKINESIA 37 0.0009
863 ADVERSE EVENT 83 0.0009
864 BLOOD URINE PRESENT 17 0.0009
865 EATING DISORDER 19 0.0009
866 DEATH 768 0.0009
867 VERTIGO 54 0.0009
868 DRUG INEFFECTIVE 1165 0.0009
869 POOR QUALITY SLEEP 19 0.0009
870 HEADACHE 545 0.0009
871 CHEST DISCOMFORT 89 0.0009
872 URINARY RETENTION 29 0.0009
873 SKIN EXFOLIATION 73 0.0009
874 MALAISE 377 0.0009
875 MUSCULOSKELETAL STIFFNESS 75 0.0009
876 SOMNOLENCE 172 0.0009
877 ATRIAL FIBRILLATION 83 0.0009
878 CYTOKINE RELEASE SYNDROME 17 0.0008
879 URINARY TRACT INFECTION 144 0.0008
880 LOSS OF CONSCIOUSNESS 108 0.0008
881 BLOOD PRESSURE DECREASED 56 0.0008
882 THERAPEUTIC RESPONSE DECREASED 51 0.0008
883 STOMATITIS 51 0.0008
884 DRUG ABUSE 70 0.0008
885 SEIZURE 96 0.0008
886 ARTHRALGIA 345 0.0008
887 DYSPNOEA 466 0.0008
888 PARAESTHESIA 129 0.0008
889 CARDIO-RESPIRATORY ARREST 34 0.0008
890 MOOD ALTERED 22 0.0008
891 ILL-DEFINED DISORDER 49 0.0008
892 CONSTIPATION 174 0.0008
893 PAIN IN EXTREMITY 233 0.0008
894 WEIGHT INCREASED 177 0.0008
895 CARDIOVASCULAR DISORDER 20 0.0008
896 DIZZINESS 384 0.0008
897 SYNCOPE 77 0.0008
898 PLASMA CELL MYELOMA 30 0.0008
899 EPISTAXIS 57 0.0008
900 SKIN DISCOLOURATION 35 0.0008
901 UNRESPONSIVE TO STIMULI 19 0.0007
902 ABDOMINAL PAIN UPPER 148 0.0007
903 TINNITUS 33 0.0007
904 PANIC ATTACK 26 0.0007
905 CARDIAC FAILURE CONGESTIVE 57 0.0007
906 HOSPITALISATION 108 0.0007
907 NECK PAIN 39 0.0007
908 OXYGEN SATURATION DECREASED 39 0.0007
909 GAIT INABILITY 23 0.0007
910 AMNESIA 44 0.0007
911 HAEMORRHAGE 70 0.0007
912 TREMOR 107 0.0006
913 INTESTINAL OBSTRUCTION 24 0.0006
914 HYPOACUSIS 27 0.0006
915 RECTAL HAEMORRHAGE 26 0.0006
916 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 33 0.0006
917 ARTHRITIS 46 0.0006
918 PRURITUS 220 0.0006
919 THROMBOSIS 46 0.0006
920 NEOPLASM MALIGNANT 38 0.0006
921 MEMORY IMPAIRMENT 77 0.0006
922 DYSPEPSIA 55 0.0006
923 MEDICATION ERROR 31 0.0006
924 BLISTER 31 0.0006
925 WRONG TECHNIQUE IN DRUG USAGE PROCESS 20 0.0005
926 VISION BLURRED 75 0.0005
927 SWELLING 51 0.0005
928 INJURY 38 0.0005
929 BRONCHITIS 40 0.0005
930 FALL 179 0.0005
931 CEREBROVASCULAR ACCIDENT 90 0.0005
932 BALANCE DISORDER 45 0.0005
933 ABDOMINAL DISCOMFORT 87 0.0005
934 EYE SWELLING 19 0.0005
935 FUNGAL INFECTION 17 0.0005
936 COVID-19 88 0.0005
937 GASTRIC DISORDER 17 0.0005
938 CRYING 18 0.0005
939 HEART RATE INCREASED 49 0.0005
940 THERAPEUTIC PRODUCT EFFECT DECREASED 22 0.0005
941 NO ADVERSE EVENT 86 0.0005
942 HAEMATOCHEZIA 26 0.0005
943 DYSPHONIA 27 0.0005
944 ROAD TRAFFIC ACCIDENT 19 0.0005
945 CATARACT 27 0.0005
946 MUSCLE SPASMS 83 0.0005
947 SINUSITIS 46 0.0004
948 URTICARIA 75 0.0004
949 BLOOD GLUCOSE INCREASED 84 0.0004
950 ADVERSE DRUG REACTION 40 0.0004
951 DYSGEUSIA 33 0.0004
952 FLATULENCE 24 0.0004
953 ALOPECIA 83 0.0004
954 OCULAR HYPERAEMIA 20 0.0004
955 ECZEMA 22 0.0004
956 MALIGNANT NEOPLASM PROGRESSION 43 0.0004
957 THERAPY CESSATION 21 0.0004
958 FEELING HOT 25 0.0004
959 DRY MOUTH 33 0.0004
960 NERVOUSNESS 21 0.0004
961 DRUG EFFECT DECREASED 21 0.0004
962 INTENTIONAL OVERDOSE 25 0.0004
963 BLOOD PRESSURE INCREASED 59 0.0004
964 CARDIAC DISORDER 36 0.0004
965 EYE PAIN 20 0.0004
966 CONTUSION 34 0.0004
967 INFLUENZA LIKE ILLNESS 29 0.0004
968 FLUSHING 35 0.0003
969 DRY EYE 17 0.0003
970 RHINORRHOEA 22 0.0003
971 VISUAL IMPAIRMENT 42 0.0003
972 ARTHROPATHY 18 0.0003
973 UNDERDOSE 23 0.0003
974 OROPHARYNGEAL PAIN 28 0.0003
975 COMPLETED SUICIDE 25 0.0003
976 BURNING SENSATION 20 0.0003
977 NASOPHARYNGITIS 52 0.0003
978 UNEVALUABLE EVENT 21 0.0003
979 FEELING ABNORMAL 63 0.0003
980 DRUG WITHDRAWAL SYNDROME 23 0.0003
981 INFLUENZA 29 0.0003
982 DRY SKIN 29 0.0002
983 MIGRAINE 20 0.0002
984 PERIPHERAL SWELLING 31 0.0002
985 INCORRECT DOSE ADMINISTERED 43 0.0002
986 ILLNESS 19 0.0002
987 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35 0.0002
989 DRUG DOSE OMISSION 21 0.0001
990 PRODUCT DOSE OMISSION ISSUE 33 0.0001